Larvol Delta - aTyr-Pharma-Presents-Additional-Findings-from-Phase-3-EFZOFIT-Study-in-LateBreaking-Oral-Abstract-at-the-European-Respiratory-Society-ERS-Congress-2025

Stalaris (efzofitimod) - aTyr Pharma, Kyorin

https://www.globenewswire.com/news-release/2025/09/30/3158359/0/en/aTyr-Pharma-Presents-Additional-Findings-from-Phase-3-EFZO-FIT-Study-in-Late-Breaking-Oral-Abstract-at-the-European-Respiratory-Society-ERS-Congress-2025.html

Sep 30, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next